retatrutide approval Will the FDA approve retatrutide? Odds & Predictions Retatrutide for weight loss: Study

Retatrutide remains investigational under Eli Lilly's TRIUMPH Phase 3 program, with results reporting through 2026

Best GLP-1 Tracker for Health Management 2025 In 2025, the best GLP-1 tracker is more than an app, it's a precision health co-pilot

Suspected side effects can be reported via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app)

None of this replaces your prescriber's advice, and it is not a promise of a fix, but understanding what is happening is a good place to start

Anti-inflammatory effects benefit mood

Too often, people wrongly think obesity is the fault of the individual, when in reality some people have a strong genetic predisposition for it, says Aaron Kelly, PhD, codirector of the Center for Pediatric Obesity Medicine at the University of Minnesota Medical School